BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, January 23, 2025
See today's BioWorld Asia
Home
» China’s ICT comes out of stealth with CAR T trial results in leukemia
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
China’s ICT comes out of stealth with CAR T trial results in leukemia
May 25, 2016
By
Shannon Ellis
No Comments
SHANGHAI – Dozens of Chinese biopharmas have entered the CAR T race, but Shanghai-based Innovative Cellular Therapeutics Co. Ltd. (ICT), also known as Sidansai in Chinese, is angling to be the front-runner.
BioWorld Asia
